News Biogen protects Tecfidera via $1.25bn deal with Forward Biogen could also pay royalties to Forward.
News Celgene broadens immunology presence with Anokion deal Biotech specialises in autoimmune disorder drugs.
News US fines Teva $519m over foreign bribery charges Teva admits it bribed officials in Russia, Ukraine and Mexico.
News Alkermes closing in on Biogen with MS rival ALKS 8700 may have fewer side effects than Tecfidera.
News Apitope to develop MS drug, Merck KGaA tie-up ends Anglo-Belgian biotech will continue clinical development.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
